Medable, Inc.

About Medable, Inc.

Medable, Inc. is an American digital-health and clinical-trial technology company headquartered in Palo Alto, California. The firm operates a cloud platform that supports the design and execution of decentralised, hybrid, and traditional clinical trials, enabling pharmaceutical sponsors, biotechnology companies, contract research organisations, investigator sites, and patients to collaborate on study build-out, electronic consent, electronic clinical outcome assessments, telehealth visits, wearable-device data capture, and patient engagement. The company was founded in 2015 by Dr. Michelle Longmire and Tim Smith. Dr. Longmire serves as chief executive officer. Medable is privately held and has raised institutional funding from investors including Sapphire Ventures, GSR Ventures, Obvious Ventures, Western Technology Investment, Streamlined Ventures, and PPD. Medable's platform is used to support clinical trials across therapeutic areas such as oncology, cardiology, neurology, dermatology, and rare diseases, with capabilities aligned to regulatory frameworks including 21 CFR Part 11, HIPAA, and GDPR. The company has been recognised as a leader in the decentralised-clinical-trial software category by industry analysts. Medable employs more than 500 people globally with offices and remote teams across North America, Europe, and Asia. India operations include an engineering and customer-services centre in Hyderabad that supports product engineering, study build, and global delivery for Medable's life-sciences customers. Indian fresher and early-career hiring at Medable targets software-engineering, quality-assurance, study-build, clinical-operations, and customer-success roles, with applications routed through medable.com/careers.

Office locations